M&A
confidence high
sentiment positive
materiality 0.85
Merck KGaA to buy Rapid Micro Biosystems for $0.75/share cash in tender offer
RAPID MICRO BIOSYSTEMS, INC.
- Merck KGaA units Parent and EMD Holdings NewCo II signed a merger agreement on Nov 16, 2026 to buy all RPID Class A and Class B shares for $0.75 cash per share.
- Tender offer runs 10 business days initially, conditioned on majority of Class A shares plus pre-funded warrant shares; merger then closes under DGCL 251(h) with no stockholder vote.
- RPID board unanimously approved and recommends the deal; holders of ~19.58% of shares, including all directors and some executives, signed tender and support agreements.
- Company would owe Parent a $1,573,000 termination fee to accept a Superior Proposal or change its recommendation; customary no-shop with fiduciary out applies.
- Warrants addressed: $1.955 Series A cashed out, $2.34 Series B bought at Black-Scholes value, $3.35 2025 warrants and $1.00 2018 warrants cancelled for no consideration.
Featured in Daily 8-K Digest
Selected #4 for 2026-11-16.
Read digest